In the fiscal year ended Sept. 30, the Justice Department obtained more than $3 billion from civil cases involving fraud and false claims against the government. The bulk of those recoveries — $2.6 billion — came from healthcare fraud cases.
Two of the largest recoveries in fiscal 2019 came from opioid manufacturers Insys Therapeutics and Reckitt Benckiser Group. Insys paid $195 million to resolve allegations that it paid kickbacks to physicians and nurse practitioners to prescribe Subsys, an addictive painkiller. RB Group paid $1.4 billion to resolve criminal and civil allegations related to the marketing of Suboxone, a formulation of the opioid buprenorphine.
The Justice Department also pursued many cases involving drug manufacturers and healthcare providers in fiscal 2019. In some cases, the Justice Department obtained recoveries from companies and their executives. One notable case in the healthcare industry involved a settlement with Vanguard Health, a Brentwood, Tenn.-based nursing home chain, and the company’s CEO and director of operations.
More articles on legal and regulatory issues:
Feds accuse Indianapolis health system of Medicare billing fraud
CHS reaches $53M deal in class-action stock drop lawsuit
Wisconsin health system will pay $10M to settle whistleblower case
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.